by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
by Randy E. Miller | Dec 13, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Reveals FOIA Requests About Establishment Labs Food and Drug Administration FOIA records released this month reveal that breast implant manufacturer Establishment Labs (NASDAQ: ESTA), previously targeted by well-known activist short-seller Hindenburg...
by Randy E. Miller | Nov 16, 2023 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine Reveals Threat of Litigation Personal injury law firm Morgan & Morgan is gearing up for what could be extensive litigation against the makers of popular weight control drugs. On October 12, the Orlando, Florida-based law firm submitted to the Food and...
by Randy E. Miller | Oct 18, 2023 | Cryptocurrency, FOIA, Politics, SEC
FOIAengine Analysis of SEC Requests Reveals Insights An analysis of Freedom of Information Act requests to the Securities and Exchange Commission over the past six months highlights investor interest in several of the leading storylines of the year, including the...
by Randy E. Miller | Sep 20, 2023 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine Identifies 57 New FOIA Requests to FDA Hedge funds and other financial institutions made 57 Freedom of Information Act (FOIA) requests last month to the Food and Drug Administration (FDA) seeking information about adverse drug events and...
